Review Version 1 Preserved in Portico This version is not peer-reviewed
3D Printing Applied to Tissue Engineered Blood Grafts
Version 1 : Received: 22 November 2018 / Approved: 26 November 2018 / Online: 26 November 2018 (11:39:44 CET)
A peer-reviewed article of this Preprint also exists.
Wenger, R.; Giraud, M.-N. 3D Printing Applied to Tissue Engineered Vascular Grafts. Appl. Sci. 2018, 8, 2631. Wenger, R.; Giraud, M.-N. 3D Printing Applied to Tissue Engineered Vascular Grafts. Appl. Sci. 2018, 8, 2631.
Abstract: The broad clinical use of synthetic vascular grafts for vascular diseases is limited by their thrombogenicity and low patency rate, especially for vessels with a diameter inferior to 6 mm. Alternatives such as tissue-engineered blood grafts (TEBGs) have gained increasing interest. Among the different manufacturing approaches, 3D bioprinting presents numerous advantages and enables the fabrication of multi-scale, multi-material, and multicellular tissues with heterogeneous and functional intrinsic structures. Extrusion-, inkjet- and light-based 3D printing techniques have been used for the fabrication of TEBG out of hydrogels, cells, and/or solid polymers. This review discusses the state-of-the-art research on the use of 3D printing for TEBG with a focus on the biomaterials and deposition methods.
3D printing; Bioprinting; Additive Manufacturing, Tissue Engineering, Blood Vessels, Vascular Grafting
Biology and Life Sciences, Anatomy and Physiology
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.Leave a public comment
Send a private comment to the author(s)